Jun Ni (Ni Jun)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Clostridium Difficile

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kang Miao, Shuangni Yu, Jun Ni, Xiao-Tong Zhang, Li Zhang
Second primary tumor after immune checkpoint inhibitor therapy: A case report. Thoracic cancer 13 (7) (2022)
Jun Ni, Xiao-Yan Si, Li Zhang
Non-small-cell lung cancer with ERBB2 mutation in non-tyrosine kinase domain benefits from pyrotinib: A case report. Thoracic cancer 12 (8) (2021)
Jun Ni, Xiao-Tong Zhang, Hanping Wang, Xiao-Yan Si, Yan Xu, Jing Zhao, Min-Jiang Chen, Li Zhang, Mengzhao Wang
Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period. Thoracic cancer 13 (4) (2021)
Xiao-Yan Si, Peng Song, Jun Ni, Mingyi Di, Chunxia He, Li Zhang, Xiaowei Liu, Yue Li, Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Xu Yang, Mengzhao Wang, Li Zhang
Management of immune checkpoint inhibitor-related adverse events: A review of case reports. Thoracic cancer 11 (3) (2020)
Jun Ni, Wang Hanping, Xiao-Yan Si, Yan Xu, Wang Mengzhao, Xiao-Tong Zhang, Zhang Li
Treatment with or without bevacizumab as a first-line and maintenance therapy for advanced non-squamous non-small cell lung cancer: A retrospective study. Thoracic cancer 11 (7) (2020)
Jun Ni, Xiaotong Zhang, Li Zhang
Opportunistic bowel infection after corticosteroid dosage tapering in a stage IV lung cancer patient with tislelizumab-related colitis. Thoracic cancer 11 (6) (2020)
Yanyan Wu, Jun Ni, Xiaoyan Chang, Xiao-Tong Zhang, Li Zhang
Successful treatment of pyrotinib for bone marrow metastasis induced pancytopenia in a patient with non-small-cell lung cancer and ERBB2 mutation. Thoracic cancer 11 (7) (2020)